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little. Within the subgroup of inconsistent pain, the pain during
activities and physical function improves. Therefore, identifying different
phenotypes in early symptomatic OA may help to better understand the
progression in OA.
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INTERMITTENT AND CONSTANT KNEE PAIN PATTERNS: AN INDICATOR
FOR RADIOGRAPHIC KNEE OA DURATION AND SEVERITY?
T. Neogi1, J. Niu1, D. Felson1, M. Nevitt2, C. Lewis3, J. Torner4, M. French5,
G. Hawker5, for The MOST Group. 1BUSM, Boston, MA, USA; 2UCSF, San
Francisco, CA, USA; 3UAB, Birmingham, AL, USA; 4UIowa, Iowa City, IA, USA;
5U of T, Toronto, ON, Canada
Purpose: Knee OA-related pain changes over time, but speciﬁc pain
patterns in relation to stage of radiographic disease is not known. It
is hypothesized that at the earliest stage of disease, persons experience
intermittent activity-related pain, while at later stages of disease the pain
becomes more constant, eventually becoming constant with episodes of
intermittent unpredictable pain. A new pain assessment tool for knee
OA, the Intermittent and Constant OA Pain (ICOAP) instrument was
developed to capture these pain patterns, but has not been tested for
this hypothesized correlation with OA duration or severity. To address
this knowledge gap, we evaluated the relationship of ICOAP-deﬁned
progressive pain patterns with radiographically-deﬁned OA duration and
severity.
Methods: The Multicenter Osteoarthritis (MOST) Study is a NIH-funded
cohort study of persons with or at high risk of knee OA. Participants
underwent bilateral knee radiography at baseline, 30, and 60 months,
which were read for OA severity according to Kellgren and Lawrence (KL)
grade. Radiographic knee OA (ROA) was deﬁned as KL ≥2. OA duration
was deﬁned according to clinic visit at which ROA was ﬁrst noted.
At the 60-month visit, knee-speciﬁc ICOAP scores were ascertained,
which assesses presence and severity of intermittent and constant
pain, and for intermittent pain, its frequency (5-point Likert scale
for each). Using the knee-speciﬁc ICOAP, pain stages were deﬁned
from early to late OA as: (1) no pain; (2) at least mild intermittent
pain occurring at least sometimes; (3) at least mild constant pain;
and (4) a combination of the latter two categories. We evaluated the
relationship between ROA duration and severity, respectively, and ICOAP
pain pattern using proportional odds logistic regression with generalized
estimating equations. We also assessed the relation of OA duration and
severity to presence of constant or constant plus intermittent pain vs.
intermittent pain alone.
Results: We studied 2112 participants (3963 knees) at the 60-month
exam who had at least one native knee (mean age 67.7±7.9, mean
BMI 30.6±6.0, 60% female). The majority of knees (63%) had no pain,
30% had intermittent pain (as deﬁned above), 3% had constant pain (as
deﬁned above), and 4% had both. 60% of knees had no ROA, 5.5% had
incident ROA at the 60-mo visit (i.e., shortest duration of OA), 5.5% had
incident ROA at the 30-mo visit, and 29.5% had ROA at the baseline visit
(i.e., longest duration of ROA). Those with longer disease and greater
radiographic severity were more likely to have the pain patterns thought
to be associated with such a disease status (i.e., both intermittent and
constant pain at the “highest” end of the ICOAP pain pattern) (Table).
This relationship for OA duration persisted when limited to only those
with ROA at any time point (Table). For constant pain vs. intermittent
only pain, there was no association for those with the shortest duration
of OA (OR 0.7, 95% CI 0.4–1.3), while those with longer durations of
OA were more likely to have constant instead of intermittent pain (ORs
(95% CI) 1.5 (0.9–2.5) for incident ROA at 30-mo; 1.4 (1.0–2.0) for longest
duration of ROA).
Conclusions: Longer duration and greater severity of ROA are associated
with greater likelihood of constant plus intermittent pain. These
ﬁndings support the prior qualitative data suggesting a progression from
intermittent to constant pain punctuated by intermittent unpredictable
pain with worsening knee OA over time. Further reﬁnement of discerning
at what stage of OA pain patterns change from being intermittent in
nature to constant and then to constant with unpredictable intermittent
pain will require further longitudinal data in which greater variety in
duration (and severity of OA) is captured along with the unpredictability
of the intermittent pain.
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Purpose: Costs related to the ﬁnal answer of progressive knee
osteoarthritis (OA), total knee replacement (TKR) surgery, are tremendous
and will increase further due to increasing prevalence of obesity and
aging in developed countries. TKR is clearly effective in reducing pain
and improving function. The outcome of revision surgery is less and even
more costly. Postponing a ﬁrst prosthesis and maintaining quality of life
is at present the major goal in treatment of end stage OA.
Speciﬁc indications for TKR surgery are not clearly deﬁned or evidence
based. Generally accepted indications are pain and restrictions in
performance in spite of the use of (non-)pharmacological interventions.
However, substantial variations in referral behaviour between health
professionals exist. Experts in the ﬁeld believe that in many patients with
severe OA conservative treatment options are not optimally prescribed.
It seems plausible that TKR surgery can be postponed or even prevented.
The aim of this explorative study is to obtain insight in characteristics
and previous pharmacological management of patients with end-stage
knee OA submitted to TKR surgery, and to explore if patients without
adequate pain medication still beneﬁt from pain medication.
Methods: 172 successive patients at the Sint Franciscus Gasthuis,
Rotterdam, referred for TKR were evaluated. Patients not using adequate
analgesics, deﬁned by no or occasional paracetamol (PCM), were
randomized to an adequate dose of an NSAID (celecoxib; 2dd200mg
daily or naproxen; 3dd250mg) or no medication for 6 weeks prior to
surgery.
Patient characteristics, severity of symptoms (WOMAC pain, stiffness and
physical function), medication use in past year and radiological features
(K&L and Altman score) were collected. To calculate the percentage
responders, modiﬁed OMERACT/OARSI responder criteria were used. A
responder was deﬁned as an improvement of ≥50% in function or pain, or
an improvement of ≥20% in pain and function. The study was conducted
according to the declaration of Helsinki and received ethics approval of
the hospital.
Results: In the year prior to referral for TKR 26% (n =44) of patients used
daily NSAIDs, another 27% (n =47) used daily PCM, or occasional NSAID,
and nearly half (47%; n =81) of patients used an occasional PCM or no
medication at all. No signiﬁcant differences in baseline characteristics or
radiographic features were found between these three groups.
Of the 81 patients not using adequate analgesics, 46 patients were
randomized to NSAID treatment and 35 were randomized to no
treatment. Patients without prior adequate pain medication treated for
6 weeks with an NSAID improved on average statistically signiﬁcant in
pain and stiffness (−5.7 [−10.9; −0.5] and −9.6 [−16.4; −2.8], resp. both
p < 0.05). 27% of the patients could be classiﬁed as an actual responder.
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Conclusions: In this explorative study most patients awaiting TKR
experienced signiﬁcant levels of pain and limitations in activities, but
surprisingly the majority did not take NSAIDs daily. Patients with
inadequate medication, who started using NSAIDs daily, improved
clinically signiﬁcantly. Further, properly designed RCTs are warranted
to study the potential effect of adequate pain medication to delay the
need for total knee replacement surgery in case of severe OA, an area
where rheumatologists can support orthopaedics.
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ASSOCIATIONS BETWEEN CLINICAL FINDINGS AND MRI
OSTEOARTHRITIS FEATURES OF THE PATELLOFEMORAL JOINT
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Purpose: The patellofemoral joint is important in osteoarthritis (OA)
of the knee, and in early detection of knee OA. Little is known
about the relationship of speciﬁc patellofemoral clinical ﬁndings and
patellofemoral MRI OA features. Therefore the purpose of this study
is to examine the relationship between clinical ﬁndings and MRI OA
features of patellofemoral joint in females aged 45 to 60 years without
radiological tibiofemoral OA.
Methods: In an open population of the Rotterdam Study (RS-I-1)
all women were invited for a sub-study of identiﬁcation of early
knee OA. Radiographs of the knees were made, as well as an MRI
of both knees. Radiographs were scored with Kellgren and Lawrence
classiﬁcation criteria. Cartilage defects, osteophytes, cysts, bone marrow
lesions and joint effusion were scored on the MRI’s. Furthermore a
physical examination of the knee was performed with speciﬁc patellar
tests and speciﬁc questions about pain in the knee and patellar knee pain
were reported in a questionnaire. Binomial logistic generalized estimated
equations were used to determine the association between the clinical
ﬁndings and MRI OA features of the patellofemoral joint (odds ratio (OR),
95% conﬁdence interval (CI)). All associations were adjusted for age, BMI
and MRI OA features of the tibiofemoral joint.
Results: In 776 women (1429 knees, mean age = 54.7 years and mean
BMI =26.7) we found signiﬁcant associations between crepitus and all
patellar MRI OA features (diffuse cartilage defects OR=5.26 (CI = 3.52–
7.85); focal cartilage defects OR=3.60 (CI = 2.28–5.69); osteophytes
OR=3.21 (CI = 2.45–4.22); cysts OR=2.73 (CI = 1.96–3.82); bone marrow
lesions OR=3.58 (CI = 2.65–4.83); joint effusion OR=1.51 (CI = 1.18–1.94).
And also between a history of patellar pain and the MRI OA features
(diffuse cartilage defects OR=2.44 (CI = 1.72–3.47); focal cartilage
defects OR=1.77 (CI = 1.15–2.71); osteophytes OR=1.68 (CI = 1.26–2.22);
cysts OR=2.06 (CI = 1.48–2.86); bone marrow lesions OR=2.18 (CI =
1.60–2.97); joint effusion OR=1.48 (CI = 1.13–1.93). Current knee pain
was signiﬁcantly associated with diffuse cartilage defects (OR=2.22,
CI = 1.38–3.59), cysts (OR=1.78, CI = 1.13–2.80), bone marrow lesions
(OR=2.11, CI = 1.39–3.19), and joint effusion (OR=1.75, CI = 1.23–2.51) at
PFJ. Furthermore patellar compression test was signiﬁcantly associated
with diffuse cartilage defects (OR=1.55, CI = 1.03–2.32), and pain at
tuberositas tibia was signiﬁcantly associated with focal cartilage defects
(OR=4.98, CI = 1.50–16.49).
Conclusions: Crepitus and a history of patellar pain are clinical ﬁndings
that indicate OA features at the patellofemoral joint in women without
radiographic tibiofemoral OA. These tests could help to indicate signs of
patellofemoral OA and follow-up data needs to conﬁrm whether these
tests have an additional diagnostic value on early stage knee OA.
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NSAIDS VERSUS ACETAMINOPHEN IN KNEE AND HIP
OSTEOARTHRITIS: A SYSTEMATIC REVIEW REGARDING
HETEROGENEITY INFLUENCING THE OUTCOMES
S.P. Verkleij, P.A. Luijsterburg, A.M. Bohnen, B.W. Koes, S.M. Bierma-
Zeinstra. Erasmus MC, Rotterdam, Netherlands
Purpose: Recent reviews reported only small improvements in pain
in favor of non-steroidal anti-inﬂammatory drugs (NSAIDs) compared
to acetaminophen in treating patients with osteoarthritis (OA), but
NSAIDs are consistently associated with substantially more side effects.
Systematic reviews integrate the results of original studies but if studies
are heterogeneous, there is no added value of pooling the results and
subgroup analyses may be needed. Statistical heterogeneity was reported
absent in systematic reviews that compared the effectiveness of NSAIDs
versus acetaminophen in treating patients with OA. Yet, clinical and
methodological heterogeneity are unknown.
The aim of our review was to identify sources of heterogeneity
(statistical, methodological, and clinical) in trials evaluating NSAIDs vs.
acetaminophen in patients with knee and hip OA to elucidate variations
in outcomes.
Methods: A search in relevant databases (1966-Jan 2010) was
made for (randomized) controlled trials ((R)CTs) comparing NSAIDs
vs. acetaminophen in knee and hip OA. Extracted data included
baseline demographic/clinical characteristics, outcomes at follow-up,
and characteristics of study design. Heterogeneity was examined with
subgroup-analyses by exploring changes in effect size and with I2
of Higgins. Pain measures were expressed as standardized mean
differences.
Results: 15 RCTs met the in- and exclusion criteria which included
21 comparisons of NSAIDs and acetaminophen. Statistical heterogeneity
was absent (Cochran’s Q-test=14.11; I2=0; p = 0.78). Moderate clinical
heterogeneity was found for comparisons which included both patients
with hip and knee OA vs. patients with knee OA only (I2=51; p =0.09).
NSAIDs seemed slightly more effective than acetaminophen if more
patients with hip OA were included. However, the pooled effect sizes
of comparisons with knee OA vs. both knee and hip OA are equal. Low
clinical heterogeneity was found for comparisons with low dosage of
acetaminophen, normal dosage of NSAIDs, and moderate pain intensity at
baseline. Low methodological heterogeneity was found for comparisons
with a short duration of follow-up.
Conclusions: Future trials should present the results of patients with hip
and knee OA separately, as moderate clinical heterogeneity was found.
There might be differences in effectiveness of NSAIDs vs. acetaminophen
in patients with hip vs. knee OA. No signiﬁcant methodological and
statistical heterogeneity was found in studies evaluating NSAIDs vs.
acetaminophen.
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Purpose: Total knee arthroplasty (TKA) is an effective therapy to control
pain and improve function in subjects with severe knee osteoarthritis
(OA). However, as the decision whether to have a joint replacement
or not is more ambiguous, it is a judgment that has to be made by
the physician and patient working together, and it has to take account
of a disability of the patient, in addition to X-ray changes. It is also
revealed that there are regional differences for the indication of TKA.
For physicians, objective indicators which represent the past results of
patients already received TKA are helpful to discuss with patients who
are considering their decision to TKA.
The use of clinical outcomes in clinical medicine is important. The
Japanese Knee Osteoarthritis Measure (JKOM) was created as a patient-
oriented outcome measure for Japanese patients with knee OA. This
measure has proven to have sufﬁcient reliability and validity by means
of statistical evaluation and comparison with the WOMAC and SF-36.
The aim of this study was to examine whether the JKOM score can
predict the risk for receiving TKA, and, if so, the cut-off of JKOM score
can be set for receiving TKA.
Methods: This study protocol was approved by the institutional review
board of our university. 227 painful medial knee OA patients with
K/L 4 were enrolled in this study. JKOM score was obtained from all
subjects on the day that radiographs taken. The signiﬁcant differences
of the data were evaluated using the Mann Whitney-U test. The AUC,
which is analogous to the area under the ROC curve, was estimated for
the discriminative value of prediction models. Odds ratios (ORs) were
calculated to evaluate the JKOM cut-off score for receiving TKA.
Results: In this study, patients were followed for 6 months on average.
While 63% of the patients were received TKA (OP group), remaining 37%
